Abstract

BackgroundAssociation between endocan and nontraditional anthropometric indices, as distinct cardiovascular disease risk factors, has not been examined in previous studies. Endocan is a novel inflammation biomarker with its higher levels involved in cardiometabolic diseases development. Taking into consideration that obesity is an independent risk factor for many cardiometabolic diseases, we aimed to explore the relationship between endocan levels and novel anthropometric indices [i.e., body adiposity index (BAI), cardiometabolic index (CMI), a body shape index, body roundness index, conicity index, lipid accumulation product index and visceral adiposity index] and traditional ones [i.e., waist circumference, hip circumference, body mass index, waist-to-height ratio and waist-to-hip ratio] in adult population.MethodsA total of 177 participants were included. Anthropometric indices and biochemical parametres were measured.ResultsUnivariate regression analysis demonstrated positive correlations of endocan and almost all anthropometric data. To explore independent associations of endocan and anthropometric parameters, the Model which fulfilled criteria for ordinal regression testing was created. Adjusted odds for BAI given in the Model (OR=1.120, 95% CI 1.036-1.212, P=0.004), demonstrated that a rise in BAI by 1 unit increased the probability of higher endocan concentration by 12%. As well, a rise in CMI for 1 unit, increased the probability for higher endocan levels for 2.6 times (OR=2.599, 95% CI 1.006-6.712, P=0.049). A total of 20.1% of variation in endocan levels could be explained by this Model.ConclusionsNon-traditional obesity indices, BAI and CMI independently correlated with higher serum endocan levels in adult population.

Highlights

  • Endocan is an intriguing proteoglycan tightly connected with endothelial dysfunction and concomitant inflammation [1]

  • Non-traditional obesity indices, body adiposity index (BAI) and cardiometabolic index (CMI) independently correlated with higher serum endocan levels in adult population

  • The others showed the positive association between circulating endocan level and mentioned obesity indices, body mass index (BMI) (16 –18) and waist circumference (WC) [18]

Read more

Summary

Introduction

Endocan is an intriguing proteoglycan tightly connected with endothelial dysfunction and concomitant inflammation [1]. Recent studies have shown higher level of this inflammation marker in many cardiometabolic diseases, such as type 2 diabetes [2], chronic kidney disease [3], fatty liver disease [4], hypertension [5]. The increased inflammation markers in adipocites and disbalance in free radicals production and antioxidant defence, increased flux of free fatty acids and dysfunction of hepatocytes, are some of the potential mechanisms linking obesity and cardiovascular disease (CVD). The others showed the positive association between circulating endocan level and mentioned obesity indices, BMI (16 –18) and WC [18]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call